July, 2023

article thumbnail

Rx Machina: How AI is transforming pharma sales

Pharmaceutical Technology

Pharma sales have undergone a seismic transformation after Covid-19, with the adoption of artificial intelligence tools.

98
article thumbnail

A pharma banking on the success of past blockbusters

PharmaVoice

180 Life Sciences is on a mission to see if the anti-TNF technology that produced a blockbuster could work for a range of other conditions.

246
246
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The AI Revolution Has Arrived: Shaping the Next Generation of Pharma Marketing

PharmExec

Join five industry leaders as they unpack the transformative potential of artificial intelligence in the pharmaceutical industry, offering insights into real-world applications and the future of life sciences marketing in an era shaped by rapid technological evolution.

119
119
article thumbnail

Opinion: Why the aspartame in Diet Coke and Coke Zero probably isn’t worth worrying about

STAT

This essay was originally published on Gideon Meyerowitz-Katz’s Medium blog. A spartame is an artificial sweetener that is used in a lot of products, including Diet Coke and Coke Zero. Like most artificial sweeteners, we have a wonderful love/hate relationship with it. It’s sweet but doesn’t have any calories, so it’s great for people who want to lose a bit of weight.

363
363
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

DigitalHealth.London’s Accelerator programme selects Aide

Pharma Times

Project aims to boost the adoption of technology across London’s NHS and help patients manage conditions - News - PharmaTimes

151
151
article thumbnail

Pfizer backs CRISPR biotech Caribou in latest cell therapy investment

BioPharma Dive

Five years after helping launch Allogene Therapeutics, Pfizer is backing another developer of “off-the-shelf” cell therapies in a deal that gives the drugmaker the chance to acquire a multiple myeloma treatment.

132
132

More Trending

article thumbnail

Following FDA’s full approval of Leqembi, here’s what else is in the Alzheimer’s pipeline

PharmaVoice

Leqembi’s U.S. approval is a milestone in Alzheimer’s research and medicine — and there are a few other late-stage biologic drugs that could follow.

246
246
article thumbnail

ISO publishes standard on bacterial endotoxin testing

European Pharmaceutical Review

The International Organization for Standardization (ISO) has published its new standard Sterilization of health care products — Microbiological methods — Part 3 Bacterial endotoxin testing ( ISO 11737-3:2023). The document contains requirements and guidance for testing for bacterial endotoxins. This includes products that must be non-pyrogenic based on either intended use or non-pyrogenic label claim, or both.

article thumbnail

Most ambulances ‘run hot’ with lights and sirens blaring. But that’s starting to change

STAT

Jonathan Studnek knows some people imagine that driving an ambulance at high speed with lights flashing and sirens wailing — racing through messily parted traffic to the scene of a crisis — is the best part of being an emergency medic. For him, that couldn’t be further from the truth. “If you’ve been in the industry for any length, you know innately: When you’re in the front of an ambulance and the lights are on, that’s the most dangerous situatio

Hospitals 302
article thumbnail

Digital health tech: a solution to substance use disorders?

Pharmaceutical Technology

Substance use disorders leave people with long-term negative mental and physical health implications and can lead to death.

130
130
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

With new data, J&J steps forward in growing race for oral autoimmune drugs

BioPharma Dive

Phase 2 results show a pill the company is developing is competitive with other oral medicines in testing against psoriasis, among them the TYK2 inhibitors that have drawn significant industry interest.

111
111
article thumbnail

Health Equity in Pharma: Communities Most Impacted by Racial Bias

PharmExec

Rose Blackburne, MD, MBA, vice president, global head, general medicine, PPD Clinical Research, Thermo Fisher Scientific, discusses health equity in pharma, specifically racial biases, and how the industry can address inequities in access and care going forward.

105
105
article thumbnail

With the neuro tide rising, could a breakthrough for Parkinson’s be next?

PharmaVoice

Amid a wave of neuro R&D, scientists are taking an Alzheimer’s-like approach to developing the first disease-modifying treatments for Parkinson’s.

246
246
article thumbnail

Episode 831: What is the role for ketamine in refractory status epilepticus?

Pharmacy Joe

In this episode, I’ll discuss the role for ketamine in status epilepticus. Episode 831: What is the role for ketamine in refractory status epilepticus? Subscribe on iTunes , Android , or Stitcher The initial therapy for status epilepticus is to use one of the following benzodiazepines: Lorazepam 0.1 mg/kg capped at 4 mg IV Midazolam 0.2 mg/kg capped at 10 mg IM Diazepam 0.15 mg/kg capped at 10 mg IV But what happens if the patient does not respond to this initial therapy?

Inpatient 105
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

What the end of affirmative action means to a fourth-year medical student

STAT

When the U.S. Supreme Court released its landmark ruling overturning the use of race-conscious college admissions, LaShyra Nolen was on clinical rotation. For Nolen, a fourth-year medical student at Harvard Medical School, the news sent a chill down her spine even though she had been anticipating it. “It felt very lonely,” said Nolen, who is Black and the first in her family to get a bachelors of science degree and attend medical school.

article thumbnail

FDA releases analysis on drug product quality in 2022

European Pharmaceutical Review

The Office of Pharmaceutical Quality (OPQ) in the US Food and Drug Administration (FDA)’s Center Pharmaceutical Quality for Drug Evaluation and Research (CDER) has released its 2022 annual report analysing drug manufacturers and their products. US drug product quality: drug recalls in FY2022 During the 2022 financial year, 166 manufacturing sites generated 912 drug recalls, the highest number of recalls in five years, according to the data.

article thumbnail

Eli Lilly’s retatrutide sets new record for weight loss in obesity space

Pharmaceutical Technology

Pipeline developments within the obesity space have recently garnered interest following recent results published on Eli Lilly’s retatrutide.

119
119
article thumbnail

Toxic Leadership in Healthcare

The Honest Apothecary

Jeremy, an HR business partner to the nursing staff of a medium sized community hospital, arrived at his desk at 8:30am on Monday to a familiar sight. There, sitting on his desk, was yet another resignation letter from a nurse on the 7th floor. Tina’s floor. Over the past 6 months Jeremy had 5 such letters reach his desk. Each one a subtle reminder to him that his organization is dealing face-to-face with the problem with toxic leadership in healthcare. “I regret to inform you that m

Hospitals 105
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

FDA’s upcoming psychedelic review looms large for a budding industry

PharmaVoice

A new psychedelic guidance from the agency gives a clue into how it could analyze drugs in the space, but industry leaders are eager for more.

246
246
article thumbnail

Women in Science: How Charco Neurotech's Lucy Jung is 'restoring joy' for Parkinson's patients

Outsourcing Pharma

Lucy Jung is the CEO and founder at Charco Neurotech, a medtech start-up which has developed the CEU1, a non-invasive wearable device for Parkinson's, that uses vibrotactile stimulation to reduce symptoms of slowness and stiffness resulting in improved movement. We spoke to her about her background, how she got involved in the Parkinson's space and her fascination for problem-solving.

105
105
article thumbnail

STAT+: Novo Nordisk bought prescribers over 450,000 meals and snacks to promote drugs like Ozempic

STAT

WASHINGTON – Novo Nordisk spent $11 million on meals and travel for thousands of doctors last year, federal records show, as part of its push to promote Ozempic and other weight loss-inducing diabetes drugs. The pharmaceutical company bought more than 457,000 meals to educate doctors and other prescribers about its portfolio of drugs known as GLP-1 agonists, according to the newly released data from the Centers for Medicare and Medicaid Services.

Diabetes 261
article thumbnail

Innovation key for boosting UK biopharma competitiveness

European Pharmaceutical Review

New recommendations to boost the competitiveness in UK biopharma and Medtech sectors have been published by Imperial College London. The ‘Sectoral Systems of Innovation and the UK’s Competitiveness’ reports assess the value-added per capita of each sector and how they compare internationally. Technological solutions and policy recommendations for government have been identified as a way to help make sectors such as biopharma and Medtech more innovative and increase their value added.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

European regulators probe suicide risk to Ozempic, other Novo drug Saxenda

BioPharma Dive

Three reports from Iceland spurred the EMA to evaluate whether certain Novo Nordisk drugs, including Ozempic, might cause thoughts of self harm.

114
114
article thumbnail

Revealed: pharma giants pour millions of pounds into NHS to boost drug sales

The Guardian - Pharmaceutical Industry

Observer investigation raises concerns about the influence of drugs companies in shaping patient care in services that use their products Pharmaceutical giants are pouring tens of millions of pounds into struggling NHS services – including paying the salaries of medical staff and funding the redesign of patient treatment – as they seek to boost drug sales in the UK, the Observer can reveal.

Diabetes 100
article thumbnail

Threads joins the social media fray. Here’s what it means for pharma marketers

PharmaVoice

Meta’s new platform is drawing Twitter comparisons and could hold potential for pharma marketers in patient and HCP communication.

article thumbnail

Complex road ahead, despite phase 3 progress, for Annovis’ buntanetap in Parkinson’s Disease

Outsourcing Pharma

Drugs like Annovis Bioâs buntanetap and prasinezumab have the potential to ârevolutionize the treatment of Parkinsonâs Diseaseâ says analytics company, GlobalData, an analytics company, but it is a complex road ahead.

106
106
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Why depression after traumatic brain injury is distinct — and less likely to respond to standard treatment

STAT

Traumatic brain injury multiplies the risk of major depression eightfold. While the emotional trauma of whatever caused such deep damage may be understandable, from a blast in a war zone to a blow on the playing field, there’s a physiological component, too, that neuroscientists have long suspected but have been unable to identify. “As clinicians, a lot of us had a gut feeling that [TBI-associated depression] is a different disease,” said Shan Siddiqi, a Harvard Medical Scho

article thumbnail

Strategies to Boost Your Pharmacy’s Front-of-House Sales

Digital Pharmacist

To boost your pharmacy’s storefront sales, the best place to start is by understanding the importance of pharmacy marketing and making sure you are taking the necessary steps to optimize your front-end sales. With the right strategies, you can increase customer loyalty, drive more sales, and establish yourself as a reliable pharmacy in your community.

article thumbnail

Novartis buys a preclinical biotech and its RNA drug technology

BioPharma Dive

For $500 million, Novartis will acquire DTx Pharma and its preclinical neurological disease drugs, marking the Swiss company’s latest investment in gene-silencing medicines.

98
article thumbnail

‘It’s naive to think this is in the best interests of the NHS.’ How Big Pharma’s millions are influencing healthcare

The Guardian - Pharmaceutical Industry

Observer investigation shows drug company money flows through the NHS, raising questions about conflict of interest When the NHS celebrated its 75th anniversary last week, it prompted a fresh debate about a healthcare system on the brink of collapse. Prof Philip Banfield, the chair of the council of the British Medical Association, warned the union’s annual meeting in Liverpool that every indicator in the NHS was “flashing red”.

100
100
article thumbnail

A leading CRO’s chief exec on why a ‘brave new world’ of clinical research is here

PharmaVoice

Peter Benton, co-CEO of Worldwide Clinical Trials, explains how the rise of the mid-sized pharma company has changed drug R&D.

246
246